US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist

2.395
+0.015+0.63%

Close May 10 16:00 ET

2.390
-0.005-0.20%

Post 16:04 ET

97.31MMarket Cap9.21P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

63.12%-10.3M

82.41%-1.42M

69.03%-694K

68.98%-2.63M

39.19%-5.55M

-151.02%-27.92M

-31.26%-8.06M

60.25%-2.24M

-161.31%-8.49M

-9.13M

Net income from continuing operations

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

-28.94%-7.25M

-140.17%-11.07M

---10.71M

Operating gains losses

-39.16%-2.18M

79.21%-131K

-158.14%-1.59M

1,061.90%808K

-439.15%-1.27M

-4,497.06%-1.56M

-1,385.71%-630K

-62.86%-614K

-113.35%-84K

---235K

Depreciation and amortization

237.93%196K

211.76%53K

260.00%54K

246.67%52K

236.36%37K

222.22%58K

-10.53%17K

-46.43%15K

--11K

Other non cash items

6,590.91%1.47M

--650K

----

--22K

----

Change In working capital

-185.90%-2.7M

70.88%-452K

-25.55%1.82M

-1,263.44%-3.25M

61.36%-816K

-34.91%-943K

-1,537.04%-1.55M

291.08%2.44M

-41.88%279K

---2.11M

-Change in prepaid assets

217.91%852K

116.45%126K

-68.36%106K

-34.21%654K

88.47%-34K

158.26%268K

-629.52%-766K

181.91%335K

-3.68%994K

---295K

-Change in payables and accrued expense

-491.76%-2.23M

-1,256.52%-624K

138.54%1.73M

-3,424.74%-3.23M

91.05%-103K

-154.57%-376K

-104.96%-46K

520.93%724K

-35.76%97K

---1.15M

-Change in other current liabilities

105.26%2K

102.86%2K

-107.14%-5K

118.42%7K

---2K

-52.00%-38K

-94.44%-70K

537.50%70K

-2.70%-38K

--0

-Change in other working capital

-66.25%-1.33M

106.57%44K

-100.76%-10K

11.89%-682K

-1.65%-677K

11.74%-797K

1.33%-670K

292.80%1.31M

-16.22%-774K

---666K

Cash from discontinued investing activities

Operating cash flow

63.12%-10.3M

82.41%-1.42M

69.03%-694K

68.98%-2.63M

39.19%-5.55M

-151.02%-27.92M

-31.26%-8.06M

60.25%-2.24M

-161.31%-8.49M

---9.13M

Investing cash flow

Cash flow from continuing investing activities

-341.76%-73.04M

166.40%30M

-6,212.45%-75.12M

-241.95%-14.71M

-279.41%-13.2M

130.44%30.21M

138.76%11.26M

-83.38%1.23M

413.08%10.36M

7.36M

Net PPE purchase and sale

46.19%-254K

98.94%-3K

73.55%-32K

0.00%-20K

-323.40%-199K

-5,144.44%-472K

-951.85%-284K

-5,950.00%-121K

39.39%-20K

---47K

Net investment purchase and sale

-337.23%-72.78M

159.85%30M

-5,662.22%-75.09M

-241.52%-14.69M

-275.59%-13M

130.92%30.68M

139.78%11.55M

-81.75%1.35M

416.66%10.38M

--7.41M

Net other investing changes

----

--2K

---1K

--0

----

Cash from discontinued investing activities

Investing cash flow

-341.76%-73.04M

166.40%30M

-6,212.45%-75.12M

-241.95%-14.71M

-279.41%-13.2M

130.44%30.21M

138.76%11.26M

-83.38%1.23M

413.08%10.36M

--7.36M

Financing cash flow

Cash flow from continuing financing activities

382.22%51.98M

-698.80%-25M

1,628.45%74.55M

6.02%2.43M

-82.20%10.78M

-92.41%4.18M

-80.27%4.31M

-100.00%-1K

2.29M

Net issuance payments of debt

--49.55M

---25M

----

--0

----

Net common stock issuance

-78.89%2.43M

--0

-100.05%-2K

--0

-18.15%2.43M

-80.81%11.5M

-89.31%4.16M

-76.79%4.38M

-100.00%-1K

--2.97M

Proceeds from stock option exercised by employees

--0

----

-90.30%62K

-99.86%20K

----

Net other financing activities

----

---783K

--0

---106K

--0

---677K

Cash from discontinued financing activities

Financing cash flow

382.22%51.98M

-698.80%-25M

1,628.45%74.55M

--0

6.02%2.43M

-82.20%10.78M

-92.41%4.18M

-80.27%4.31M

-100.00%-1K

--2.29M

Net cash flow

Beginning cash position

47.38%40.46M

-83.53%5.47M

-77.36%6.77M

-13.81%24.1M

47.38%40.46M

-64.46%27.46M

-42.18%33.2M

-11.58%29.89M

87.31%27.97M

--27.46M

Current changes in cash

-339.86%-31.36M

-51.46%3.58M

-138.41%-1.27M

-1,026.50%-17.34M

-3,203.04%-16.32M

126.25%13.07M

-62.83%7.37M

-86.02%3.3M

-90.08%1.87M

--526K

Effect of exchange rate changes

15.63%-54K

107.62%8K

-1,133.33%-31K

-86.79%7K

-153.33%-38K

-811.11%-64K

-3,400.00%-105K

200.00%3K

783.33%53K

---15K

End cash Position

-77.62%9.06M

-83.53%5.47M

-77.36%6.77M

-13.81%24.1M

47.38%40.46M

-47.62%40.46M

-42.18%33.2M

-11.58%29.89M

--27.97M

Free cash flow

62.87%-10.55M

83.02%-1.42M

69.26%-726K

68.81%-2.65M

37.33%-5.75M

-155.27%-28.41M

-35.68%-8.37M

58.12%-2.36M

-159.29%-8.51M

---9.17M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	63.12%-10.3M	82.41%-1.42M	69.03%-694K	68.98%-2.63M	39.19%-5.55M	-151.02%-27.92M	-31.26%-8.06M	60.25%-2.24M	-161.31%-8.49M	-9.13M
Net income from continuing operations	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M	-28.94%-7.25M	-140.17%-11.07M	---10.71M
Operating gains losses	-39.16%-2.18M	79.21%-131K	-158.14%-1.59M	1,061.90%808K	-439.15%-1.27M	-4,497.06%-1.56M	-1,385.71%-630K	-62.86%-614K	-113.35%-84K	---235K
Depreciation and amortization	237.93%196K	211.76%53K	260.00%54K	246.67%52K	236.36%37K	222.22%58K	-10.53%17K	-46.43%15K	-46.43%15K	--11K
Other non cash items	6,590.91%1.47M	--650K	----	----	----	--22K	----	----	----	----
Change In working capital	-185.90%-2.7M	70.88%-452K	-25.55%1.82M	-1,263.44%-3.25M	61.36%-816K	-34.91%-943K	-1,537.04%-1.55M	291.08%2.44M	-41.88%279K	---2.11M
-Change in prepaid assets	217.91%852K	116.45%126K	-68.36%106K	-34.21%654K	88.47%-34K	158.26%268K	-629.52%-766K	181.91%335K	-3.68%994K	---295K
-Change in payables and accrued expense	-491.76%-2.23M	-1,256.52%-624K	138.54%1.73M	-3,424.74%-3.23M	91.05%-103K	-154.57%-376K	-104.96%-46K	520.93%724K	-35.76%97K	---1.15M
-Change in other current liabilities	105.26%2K	102.86%2K	-107.14%-5K	118.42%7K	---2K	-52.00%-38K	-94.44%-70K	537.50%70K	-2.70%-38K	--0
-Change in other working capital	-66.25%-1.33M	106.57%44K	-100.76%-10K	11.89%-682K	-1.65%-677K	11.74%-797K	1.33%-670K	292.80%1.31M	-16.22%-774K	---666K
Cash from discontinued investing activities
Operating cash flow	63.12%-10.3M	82.41%-1.42M	69.03%-694K	68.98%-2.63M	39.19%-5.55M	-151.02%-27.92M	-31.26%-8.06M	60.25%-2.24M	-161.31%-8.49M	---9.13M
Investing cash flow
Cash flow from continuing investing activities	-341.76%-73.04M	166.40%30M	-6,212.45%-75.12M	-241.95%-14.71M	-279.41%-13.2M	130.44%30.21M	138.76%11.26M	-83.38%1.23M	413.08%10.36M	7.36M
Net PPE purchase and sale	46.19%-254K	98.94%-3K	73.55%-32K	0.00%-20K	-323.40%-199K	-5,144.44%-472K	-951.85%-284K	-5,950.00%-121K	39.39%-20K	---47K
Net investment purchase and sale	-337.23%-72.78M	159.85%30M	-5,662.22%-75.09M	-241.52%-14.69M	-275.59%-13M	130.92%30.68M	139.78%11.55M	-81.75%1.35M	416.66%10.38M	--7.41M
Net other investing changes	----	----	----	----	----	--2K	---1K	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-341.76%-73.04M	166.40%30M	-6,212.45%-75.12M	-241.95%-14.71M	-279.41%-13.2M	130.44%30.21M	138.76%11.26M	-83.38%1.23M	413.08%10.36M	--7.36M
Financing cash flow
Cash flow from continuing financing activities	382.22%51.98M	-698.80%-25M	1,628.45%74.55M	0	6.02%2.43M	-82.20%10.78M	-92.41%4.18M	-80.27%4.31M	-100.00%-1K	2.29M
Net issuance payments of debt	--49.55M	---25M	----	----	----	--0	--0	----	----	----
Net common stock issuance	-78.89%2.43M	--0	-100.05%-2K	--0	-18.15%2.43M	-80.81%11.5M	-89.31%4.16M	-76.79%4.38M	-100.00%-1K	--2.97M
Proceeds from stock option exercised by employees	--0	--0	----	----	----	-90.30%62K	-99.86%20K	----	----	----
Net other financing activities	----	----	----	----	----	---783K	--0	---106K	--0	---677K
Cash from discontinued financing activities
Financing cash flow	382.22%51.98M	-698.80%-25M	1,628.45%74.55M	--0	6.02%2.43M	-82.20%10.78M	-92.41%4.18M	-80.27%4.31M	-100.00%-1K	--2.29M
Net cash flow
Beginning cash position	47.38%40.46M	-83.53%5.47M	-77.36%6.77M	-13.81%24.1M	47.38%40.46M	-64.46%27.46M	-42.18%33.2M	-11.58%29.89M	87.31%27.97M	--27.46M
Current changes in cash	-339.86%-31.36M	-51.46%3.58M	-138.41%-1.27M	-1,026.50%-17.34M	-3,203.04%-16.32M	126.25%13.07M	-62.83%7.37M	-86.02%3.3M	-90.08%1.87M	--526K
Effect of exchange rate changes	15.63%-54K	107.62%8K	-1,133.33%-31K	-86.79%7K	-153.33%-38K	-811.11%-64K	-3,400.00%-105K	200.00%3K	783.33%53K	---15K
End cash Position	-77.62%9.06M	-77.62%9.06M	-83.53%5.47M	-77.36%6.77M	-13.81%24.1M	47.38%40.46M	-47.62%40.46M	-42.18%33.2M	-11.58%29.89M	--27.97M
Free cash flow	62.87%-10.55M	83.02%-1.42M	69.26%-726K	68.81%-2.65M	37.33%-5.75M	-155.27%-28.41M	-35.68%-8.37M	58.12%-2.36M	-159.29%-8.51M	---9.17M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall